Camila Adarvez-Feresin

Ms. Camila Adarvez-Feresin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Archiv der Pharmazie
Verified
Journal Article
Closed access
CACamila Adarvez-Feresin
Camila Adarvez-Feresin
JOJavier E. Ortiz
Javier E. Ortiz
Mauricio PiñeiroMauricio Piñeiro
Mauricio Piñeiro
OPOscar Parravicini
Oscar Parravicini
RERicardo Enriz
Ricardo Enriz
Gabriela Egly FeresinGabriela Egly Feresin
Gabriela Egly Feresin

8 September 2025 in Compounds
Verified
Journal Article
Open access
PDF file
JOJavier E. Ortiz
Javier E. Ortiz
CACamila Adarvez-Feresin
Camila Adarvez-Feresin
OLOlimpia Llalla-Córdova
Olimpia Llalla-Córdova
DCDiego Sebastián Cristos
Diego Sebastián Cristos
AGAdriana Garro
Adriana Garro
Gabriela Egly FeresinGabriela Egly Feresin
Gabriela Egly Feresin
Neurodegenerative diseases, including Alzheimer’s disease (AD), represent one of the main global health challenges. Cannabis sativa synthesizes spermidine-type alkaloids, whose potential biological activities have been little studied. This study aimed to isolate bioactive alkaloids from an alkaloid-enriched extract (AEE) of C. sativa roots throughout a bioguided approach using conventional chromatographic techniques based on AChE and BuChE inhibitory activities. A qualitative and semiquantitative analysis by UPLC-ESI-MS/MS as well as molecular modeling simulations were performed. In addition, predictive in silico analyses were conducted to assess toxicity properties. The alkaloids cannabisativine (CS) and anhydrocannabisativine (ACS) were isolated, and showed highly selective BuChE inhibitory activity. The molecular modeling study revealed a conserved interaction profile across both alkaloids, indicating the amino acids TRP82, GLU197, TYR440, and HIS438 as the major contributors involved in the complex formation. Finally, CS and ACS exhibited low in silico predictive toxicity values. In conclusion, CS and ACS alkaloids emerge as new selective BuChE inhibitors with therapeutic potential that deserves the attention from the field of pharmacology in neurodegenerative disease research. Additionally, this approach promotes innovation and environmental sustainability through the use of C. sativa roots.

7 January 2026 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
CACamila Adarvez-Feresin
Camila Adarvez-Feresin
EAEmilio Angelina
Emilio Angelina
OPOscar Parravicini
Oscar Parravicini
RERicardo D. Enriz
Ricardo D. Enriz
AGAdriana Garro
Adriana Garro

Verified
Journal Article
Open access
PDF file
SKSiva Hariprasad Kurma
Siva Hariprasad Kurma
CACamila Adarvez-Feresin
Camila Adarvez-Feresin
OPOscar Parravicini
Oscar Parravicini
AGAdriana Garro
Adriana Garro
ŠŠŠárka Štěpánková
Šárka Štěpánková
AIAleš Imramovský
Aleš Imramovský
In the present work, a novel series of eleven sulfonate derivatives with potent inhibitory activity against butyrylcholinesterase (BChE) is reported. Of these, compounds 2-[(E)-(2-Benzoylhydrazinylidene)methyl]phenyl 5-(dimethylamino)naphthalene-1-sulfonate (5c, IC50 = 1.11 µM) and tert-butyl (2E)-2-[(2-{[5-(dimethylamino)naphthalene-1-sulfonyl]oxy}phenyl)methylidene]hydrazine-1-carboxylate (5b, IC50 = 11.51 µM) exhibit stronger inhibitory activity than rivastigmine, the reference compound, and exhibit high selectivity for BChE over AChE (e.g., selectivity index 57 for 5c). Interestingly, compound 5c also exhibited anti-inflammatory effects, which is important for potential therapeutic applications, especially in Alzheimer’s disease. These new compounds were designed through a structure-based approach using molecular modeling techniques (docking, molecular dynamic (MD) simulations, and QTAIM (quantum theory of atoms in molecules) calculations). The most promising compounds show no detectable toxic effects and satisfy Lipinski’s rule of five, indicating that they represent attractive starting structures for the design of new derivatives acting as specific BChE inhibitors. In addition, our results indicate that relatively simple computational techniques such as docking calculations and toxicity prediction programs can be valuable when properly used in the search of new candidates for this particular target. Docking calculations show that the more active compounds of this series reach the bottom region of the gorge interacting with residues within the active site of BChE. However, our data further suggest that the use of more precise techniques, such as MD simulations and QTAIM analysis, is necessary to obtain detailed insight into ligand–enzyme interactions. Regarding QTAIM calculations, they demonstrate that such computations are very useful to evaluate the molecular interactions of the different molecular complexes. In summary, we report a new series of sulfonate derivatives as promising starting structures for the development of new selective BChE inhibitors.